Treatment effects of the traditional Chinese medicine Shenks in bleomycin-induced lung fibrosis through regulation of TGF-beta/Smad3 signaling and oxidative stress-Reference-Cited by-同舟云学术

Treatment effects of the traditional Chinese medicine Shenks in bleomycin-induced lung fibrosis through regulation of TGF-beta/Smad3 signaling and oxidative stress

Published:2017-05-22 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Chu Haiyan,Shi Ying,Jiang Shuai,Zhong Qicheng,Zhao Yongqiang,Liu Qingmei,Ma Yanyun,Shi Xiangguang,Ding Weifeng,Zhou Xiaodong,Cui Jimin,Jin Li,Guo Gang,Wang Jiucun

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-02293-z.pdf

Reference45 articles.

1. Wolters, P. J., Collard, H. R. & Jones, K. D. Pathogenesis of idiopathic pulmonary fibrosis. Annual review of pathology 9, 157–179, doi: 10.1146/annurev-pathol-012513-104706 (2014).

2. Herzog, E. L. et al. Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct? Arthritis & rheumatology 66, 1967–1978, doi: 10.1002/art.38702 (2014).

3. Veraldi, K. L., Hsu, E. & Feghali-Bostwick, C. A. Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung disease. Current rheumatology reports 12, 19–25, doi: 10.1007/s11926-009-0071-8 (2010).

4. Noble, P. W., Barkauskas, C. E. & Jiang, D. Pulmonary fibrosis: patterns and perpetrators. The Journal of clinical investigation 122, 2756–2762, doi: 10.1172/JCI60323 (2012).

5. Toonkel, R. L., Hare, J. M., Matthay, M. A. & Glassberg, M. K. Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing. American journal of respiratory and critical care medicine 188, 133–140, doi: 10.1164/rccm.201207-1204PP (2013).

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective effects of E-CG-01 (3,4-lacto cycloastragenol) against bleomycin-induced lung fibrosis in C57BL/6 mice;Biomedicine & Pharmacotherapy;2024-08

2. Chinese medicine as a therapeutic option for pulmonary fibrosis: Clinical efficacies and underlying mechanisms;Journal of Ethnopharmacology;2024-01

3. Therapeutic potential of traditional Chinese medicine for interstitial lung disease;Journal of Ethnopharmacology;2024-01

4. The mechanism and application of traditional Chinese medicine extracts in the treatment of lung cancer and other lung-related diseases;Frontiers in Pharmacology;2023-12-06

5. Traditional Herbal Medicines, Bioactive Compounds, and Plant Products as Therapeutic Approach Against Interstitial Lung Disease;Genetic Manipulation of Secondary Metabolites in Medicinal Plant;2023